Untitled

[innovationtrends]

Multiple Sclerosis Therapeutics Market Overview with Future Growth and Forecast to 2020-2027

Multiple Sclerosis Therapeutics Market 2020 Global Industry Market research report provides key analysis on the market status of the Multiple Sclerosis Therapeutics manufacturers with market size, growth, share, trends as well as industry cost structure. Granular market information gathered in this Multiple Sclerosis Therapeutics report will be helpful to Multiple Sclerosis Therapeutics industry to take competent business decisions. This global market research report is a window for the complete overview of the market where it covers various aspects such as product definition, segmentation based on various parameters, and the prevailing vendor landscape. The research study carried out in Multiple Sclerosis Therapeutics report also helps to recognize the various drivers and restraints impacting the market during the forecast period. By applying consistent knowledge throughout the report, research, analysis and estimations are drawn in this Multiple Sclerosis Therapeutics market report.

Global Multiple Sclerosis Therapeutics Market: Regional Analysis

The report offers in-depth assessment of the growth and other aspects of the Multiple Sclerosis Therapeutics market in important regions. Key regions covered in the report are North America, Europe, Asia-Pacific and Latin America.

The report has been curated after observing and studying various factors that determine regional growth such as economic, environmental, social, technological, and political status of the particular region. Analysts have studied the data of revenue, production, and manufacturers of each region. This section analyses region-wise revenue and volume for the forecast period of 2020 to 2027. These analyses will help the reader to understand the potential worth of investment in a particular region.

Global Multiple Sclerosis Therapeutics Market: Competitive Landscape

This section of the report identifies various key manufacturers of the market. It helps the reader understand the strategies and collaborations that players are focusing on combat competition in the market. The comprehensive report provides a significant microscopic look at the market. The reader can identify the footprints of the manufacturers by knowing about the global revenue of manufacturers, during the forecast period of 2020 to 2027.

Major Key Points of Multiple Sclerosis Therapeutics Market

Multiple Sclerosis Therapeutics Market Overview

Multiple Sclerosis Therapeutics Market Competition

Multiple Sclerosis Therapeutics Market, Revenue and Price Trend

Multiple Sclerosis Therapeutics Market Analysis by Application

Company Profiles and Key Figures in Multiple Sclerosis Therapeutics Market

Market Dynamics

Methodology and Data Source

Leading market players and manufacturers are studied to help give a brief idea about them in the report. The challenges faced by them and the reasons they are on that position is explained to help make a well informed decision. Competitive landscape of Brown Sugar market is given presenting detailed insights into the company profiles, developments, merges, acquisitions, economic status and best SWOT analysis.

NOTE: Our team is studying Covid-19 and its impact on various industry verticals and wherever required we will be considering Covid-19 analysis of markets and industries. Cordially get in touch for more details.

TABLE OF CONTENTS

Introduction

Key Takeaways

Research Methodology

Multiple Sclerosis Therapeutics Market Landscape

Multiple Sclerosis Therapeutics Market - Key Market Dynamics

Multiple Sclerosis Therapeutics Market - Global Market Analysis

Multiple Sclerosis Therapeutics Market - Revenue and Forecasts To 2027 - Segmentation

Overview

Multiple Sclerosis Therapeutics Market Revenue and Forecasts To 2027 - Geographical Analysis

Industry Landscape

Multiple Sclerosis Therapeutics Market, Key Company Profiles

Appendix

About Us:

The Insight Partners is a one stop industry research provider of actionable intelligence. We help our clients in getting solutions to their research requirements through our syndicated and consulting research services. We specialize in industries such as Semiconductor and Electronics, Aerospace and Defense, Automotive and Transportation, Biotechnology, Healthcare IT, Manufacturing and Construction, Medical Device, Technology, Media and Telecommunications, Chemicals and Materials.

Contact Us:

If you have any queries about this report or if you would like further information, please

Contact Person: Sameer Joshi

E-mail: [email protected]

Phone: [phone]

[innovationtrends]

Malaria Treatment Market Size, Global Analytical Overview, Key Players, Regional Demand, Trends and Forecast to 2028

The malaria treatment market was valued at US$ 1,638.27 million in 2021; registering at a CAGR of 4.9% from 2022 to 2028, according to a new research study conducted by The Insight Partners.

Oral Segment to Lead Malaria Treatment Market During 2022–2028

The report highlights the key factors driving the market and prominent players with their developments. The market growth is primarily attributed to an increasing prevalence of malaria and the government and private sector's initiatives to raise awareness about malaria. However, counterfeit antimalarial drugs and subsequent drug resistance are hindering the market growth.

According to the World Health Organization (WHO), malaria is an acute febrile illness caused by plasmodium parasites, which spread through the bites of infected female Anopheles mosquitoes. Malaria is caused by five parasite species in humans, and two of these species—Plasmodium falciparum and P. vivax pose the greatest threat. P. falciparum is the deadliest malarial parasite, and it is the most widespread one on the African continent. P. vivax is the dominant malarial parasite in most countries outside of sub-Saharan Africa. According to the World malaria report (WMR) 2020 by the WHO, 241 million cases of malaria were reported in 2020, compared to 227 million cases recorded in 2019. The number of deaths caused due to malaria reached 0.62 million in 2020, with an annual rise of 69,000 deaths. While approximately two-thirds of these deaths (47,000) were due to disruptions in healthcare services during the COVID-19 pandemic, the remaining one-third of deaths (22,000) reflected a recent change in WHO’s methodology for calculating malaria mortality (irrespective of COVID-19 disruptions). As per the WHO, Africa continues to account for a disproportionately high share of the global burden of malaria. In 2020, 95% of the global cases of malaria and 96% of deaths were reported in Africa; ~80% of the total deaths caused by malaria are reported in children below 5 years of age. Four African countries Nigeria (31.9%), the Democratic Republic of the Congo (13.2%), the United Republic of Tanzania (4.1%), and Mozambique (3.8%) accounted for nearly half of all malaria-related deaths reported worldwide. According to the LANCET Regional Health 2020, the burden of malaria is the highest in African countries (95%); P. falciparum is the cause of the brunt of mortality in children younger than 5 (∼77%) across the world, and in African countries, this species accounts for ∼96% of total mortalities caused among children by malaria. Furthermore, P. vivax has been a causal agent of 2% (4.5 million) of the total cases, mostly from Asia. According to WMR 2021, ∼2% of the global burden of malaria is borne by Southeast Asian countries, and India contributed 83% of estimated malaria cases and 82% of malaria deaths in Southeast Asia in 2020. Hence, the rising prevalence of malaria in different regions of the world boosts the malaria treatment market growth.

Moreover, counterfeit antimalarial drugs and subsequent drug resistance hinder the overall malaria treatment market growth. The resistance spreading among plasmodium species against existing antimalarial drugs is a growing concern. The World malaria report 2021 by the WHO has highlighted the emergence of partial resistance to artemisinin in Africa. The occurrence of antimalarial drug resistance can be due to the growing appearance and use of counterfeit drugs, overuse of certain medications for prevention, incomplete treatment of active infections, and the parasite's adaptability at the genetic and metabolic levels, among others. The elevated prevalence of counterfeit antimalarial drugs is a major concern faced by healthcare sectors worldwide. These drugs are dominant in most African countries; since medical costs are high in these countries, people may opt for counterfeits for receiving treatments at lower costs, while some countries lack reasonable quality control and verification processes. According to the Journal of Vector Borne Diseases 2020, counterfeit antimalarial drugs not only result in an economic loss but also decrease the efficacy of treatment resulting in the loss of faith in the health system and increasing the chances of drug resistance in the parasites. Counterfeit drugs also hamper the intellectual property-based innovation paradigms. The presence of counterfeit antimalarial drugs significantly leads to a rise in the number of deaths in developing countries. Thus, the surging dominance of counterfeit antimalarial drugs and the subsequent rise in drug resistance among plasmodium species are hindering the malaria treatment market growth.       

Based on route of administration, the malaria treatment market is segmented into oral, parenteral & intravenous. The oral segment held the largest share of the market in 2021, and it is also expected to grow rapidly during the forecast period. Oral drug delivery is the most preferred and suitable route of drug administration in malaria patients as it offers high patient compliance, noninvasiveness, least sterility constraints, cost-effectiveness, flexibility in the design of dosage form, and ease in the manufacturing process. Benefits such as ease of administration and long-term cost efficiency are major factors fueling the adoption of oral drugs. The low manufacturing cost of tablets, capsules, and other orally administered drugs acts as a driving factor for the malaria treatment market growth. A few of the available anti-malarial drugs are quinine, quinidine, chloroquine, amodiaquine, tafenoquine proguanil, chlorproguanil, and artemisinin. ACTs and the combination therapies are being used for the treatment of uncomplicated malaria caused by P. falciparum parasite. ACTs are the most effective antimalarial medicines in the market, acting as a standalone factor responsible for the market growth in the oral segment.

Zydus Healthcare Ltd, Sun Pharmaceutical Industries Ltd, Sanofi SA, GSK Plc, Novartis AG, Cipla Ltd, Viatris Inc, Lupin Ltd, AdvaCare Pharma USA LLC, and VLP Therapeutics LLC are among the leading companies operating in the malaria treatment market.

The report segments the malaria treatment market as follows:

Based on treatment, the malaria treatment market is segmented into prescription medications, vaccines, diagnostic tests, and others. Based on drug type, the malaria treatment market is bifurcated into branded and generic. Based on route of administration, the malaria treatment market is bifurcated into oral and parenteral & intravenous. Based on distribution channel, the malaria treatment market is segmented into direct tender, hospital pharmacies, retail pharmacies, online pharmacies, and others. Based on end user, the malaria treatment market is segmented into hospitals, specialty clinics, homecare, and others. By geography, the malaria treatment market is segmented into North America (US, Canada, and Mexico), Europe (UK, Germany, France, Italy, Spain, and the Rest of Europe), Asia Pacific (China, Japan, India, Australia, South Korea, and the Rest of Asia Pacific), the Middle East & Africa (UAE, Saudi Arabia, Africa, Nigeria, Democratic Republic of Congo, United Republic of Tanzania, Mozambique, Uganda, Ghana, Burkina Faso, Kenya, Zambia, and the Rest of Middle East & Africa), and South & Central America (Brazil, Argentina, and the Rest of South & Central America).

Reason to Buy

Save and reduce time carrying out entry-level research by identifying the growth, size, leading players and segments in the global Malaria Treatment Market.

Highlights key business priorities in order to guide the companies to reform their business strategies and establish themselves in the wide geography.

The key findings and recommendations highlight crucial progressive industry trends in the Malaria Treatment Market, thereby allowing players to develop effective long-term strategies in order to garner their market revenue. 

Develop/modify business expansion plans by using substantial growth offering developed and emerging markets.

Scrutinize in-depth global market trends and outlook coupled with the factors driving the market, as well as those restraining the growth at a certain extent.

Order a copy of this research Malaria Treatment Market research report at –

Enhance the decision-making process by understanding the strategies that underpin commercial interest with respect to products, segmentation and industry verticals.

About Us:

The Insight Partners is a one stop industry research provider of actionable intelligence. We help our clients in getting solutions to their research requirements through our syndicated and consulting research services. We specialize in industries such as Semiconductor and Electronics, Aerospace and Defense, Automotive and Transportation, Biotechnology, Healthcare IT, Manufacturing and Construction, Medical Device, Technology, Media and Telecommunications, Chemicals and Materials.

Contact Us:

If you have any queries about this report or if you would like further information, please contact us:

Contact Person: Sameer Joshi

E-mail: [email protected] Phone: [phone]

[innovationtrends]

Pharmaceutical Excipients Market Size, Growth, Industry Trends, Global Demand, and Forecast 2023-2028

The rising number of product approvals and launches drives the pharmaceutical excipients market growth. Formulation scientists have recognized that single-component excipients do not always provide the requisite performance to allow certain APIs to be manufactured adequately. These scientists focus on the production of co-processed and multifunctional excipients with enhanced performance.  Co-processed excipients are a mixture of two or more existing excipients at the sub-particle level, offering substantial benefits of the incorporated excipients and minimizing their drawbacks. These multipurpose excipients have dramatically reduced the number of incorporating excipients in the tablet. The co-processed excipients are used to improve the drug's flow, disintegration, lubrication, and compressibility. The excipients also simplify the formulation process and make it cost-effective. They are increasingly used to convert complicated and labor-intensive formulation processes, such as wet granulation, to quick direct-compression processes, without affecting the final product quality or performance. Co-processed excipients play a crucial role in the creation of a stable, result-oriented drug delivery system with enhanced chemical, physical, and mechanical properties.

Grab PDF to Know More (Including Table, Full TOC and Figures) @ https://www.theinsightpartners.com/sample/TIPRE00003534/  

Excipients are an integral component of pharmaceutical products that determine the structure of dosage type and its role in delivering drugs. Excipients significantly affect the process ability, aesthetics, efficiency, and patient compliance with the dosage form. Thus, the use of excipients in a formulation requires an assurance and a clear understanding of their quality, safety, and performance attributes. The principal role of excipients is to support patient acceptability, enhance stability, bioavailability, and assist in the effectiveness.

Thus, the rise in the sale of generic drugs across the world propels the demand for pharmaceutical excipients used in manufacturing generic drugs.

Based on type, the pharmaceutical excipients market is segmented into bioresorbable polymers, lipids, and liposome-based formulation; oleochemicals; sugars; cellulose; starches; petrochemicals; plant proteins, polyols and cyclodextrins; inorganic chemicals; and others. The inorganic chemicals segment is expected to account for the largest share of the market in 2022. However, the plant proteins, polyols and cyclodextrins segment is anticipated to register the highest CAGR in the market during the forecast period.

JRS PHARMA GmbH & Co KG, Roquette Freres SA, BASF SE, Evonik Industries AG, AshLand Inc, Archer-Daniels-Midland Co, The Dow Chemical Co, The Lubrizol Corp, Avantor Inc, and MEGGLE GmbH & Co KG., Univar Solutions Inc. are a few of the key companies operating in the pharmaceutical excipients market.

The report segments the pharmaceutical excipients market as follows:

The pharmaceutical excipients market is segmented based on type, clinical indication, functionality, application, end user, and geography. Based on type, the market is segmented into bioresorbable polymers, lipids, and liposome-based formulation; oleochemicals; sugars; cellulose; starches; petrochemicals; plant proteins, polyols and cyclodextrins; inorganic chemicals; and others. Based on clinical indication, the market is segmented into cancer, metabolic, infectious diseases, dental, ophthalmic, gene therapies, and others.

Based on functionality, the market is segmented into coloring agent & coating agent; sweetener & flavoring agents; suspending & viscosity agents; preservative & controlled-release; antioxidant & oil; tablet filler & diluents; binders, compression aids and granulating agents; and others. Based on application, the market is segmented into parenteral, oral formulations & tablets, capsules, liquid & injectables, physicochemical excipient-container interactions in prefilled syringes, nutraceuticals & OTC, topical, and others. Based on end user, the market is segmented into biopharma industries, pharma industries, animal health, and others.

By geography, the pharmaceutical excipients market is segmented into North America (US, Canada, and Mexico), Europe (UK, Germany, France, Italy, Spain, and the Rest of Europe), Asia Pacific (China, Japan, India, Australia, South Korea, and the Rest of Asia Pacific), the Middle East & Africa (UAE, Saudi Arabia, Africa, and the Rest of MEA), and South & Central America (Brazil, Argentina, and the Rest of SAM).

About US

The Insight Partners is a one stop industry research provider of actionable intelligence. We help our clients in getting solutions to their research requirements through our syndicated and consulting research services. We specialize in industries such as Semiconductor and Electronics, Aerospace and Defense, Automotive and Transportation, Biotechnology, Healthcare IT, Manufacturing and Construction, Medical Device, Technology, Media and Telecommunications, Food and Beverages, Consumers and Goods, Chemicals and Materials.

Contact US

Contact Person : Sameer Joshi .

Phone : [phone]

E-mail : [email protected]

[innovationtrends]

Brain Health Supplements Market Size, Growth, Industry Trends, Global Demand, and Forecast 2023-2028

The global brain health supplements market is expected to reach at US$ 14,249.53 million by 2028. registring at a CAGR of 11.7% from 2022 to 2028, according to a new research study conducted by The Insight Partners.

Natural Molecules Segment to Lead Brain Health Supplements Market During 2022–2028

According to our latest study on "Brain Health Supplements Market Forecast to 2028 – COVID-19 Impact and Global Analysis – by Product, Application, Dosage Form, Distribution Channel, and Age Category," the market is expected to grow from US$ 6,634.3 million in 2021 to US$ 14,249.5 million by 2028; it is estimated to grow at a CAGR of 11.7% from 2022 to 2028.

The report highlights the key factors driving the market and prominent players with their developments. The growing prevalence of major depressive disorders and increasing demand for brain supplements among the elderly population primarily boost the market growth. However, the lack of regulations and false claims by manufacturers hinder the growth of the brain health supplements market.

Grab PDF to Know More (Including Table, Full TOC and Figures) @ https://www.theinsightpartners.com/sample/TIPRE00007430/  

Depression, which is a common mental disorder, is different from normal mood fluctuations and temporary emotional responses to challenges faced every day. When depression is recurrent with moderate or severe intensity, it may become a severe health issue. It can hamper the performance of affected individuals in homes, workplaces, schools, etc. People suffering from depression are also likely to attempt suicide. According to estimates by the World Health Organization (WHO), 5% of adults (~280 million) suffer from depression globally. Further, according to the National Institute of Mental Health (NIMH), in the US, ~14.8 million adults aged 18 and above (i.e., 6.0% of the total adult population) had at least one major depressive episode with serious impairment in 2020.

Cases of chronic depression are increasing in Europe. According to Eurostat, in 2019, 7.2% of European Union (EU) citizens had chronic depression. In European Union (EU), 12.2% of people in Portugal reported having chronic depression in 2019, followed by Sweden (11.7%), and Germany and Croatia (11.6% both). Per the data published by KPMG International, the prevalence of depression is higher in Asia Pacific compared to the rest of the world, especially in the younger population. According to the National Center for Biotechnology Information (NCBI), there is growing evidence about the role of nutrients in mental health. The adequate consumption of nutrients contributes to better overall health and mental health. Hence, the optimum supply of nutrients as adjunctive therapy to antidepressants is essential for adequate brain functioning. Thus, the growing prevalence of major depressive disorders is driving the growth of the brain health supplements market.

Based on product, the brain health supplements market is segmented into natural molecules, herbal extracts, and vitamins & minerals. The natural molecules segment held the largest share of the market in 2021, and it is also expected to record rapid growth during the forecast period. According to a report by the Uniformed Services University, brain health supplements are mostly natural or herbal nootropics (smart drugs and cognitive enhancers, similar to adaptogens) that include ingredients such as ashwagandha, Bacopa monnieri, Ginkgo biloba, ginseng, huperzine A, omega-3 fatty acids, rhodiola, and valerian. Natural molecules are increasingly being used as supplements as no or negligible side effects are associated with them. Further, nootropic supplement ingredients such as higenamine, sulbutiamine, and hordenine are approved by the US Food and Drug Administration (FDA) under the "Dietary Supplement Ingredient Advisory List" based on the preliminary evaluation for the ingredients not appearing to be lawfully included and sold under dietary supplement products.

Health Via Modern Nutrition Inc. (HVMN Inc.); Unilever PLC; Quincy Bioscience; Peak Nootropics; Danone SA; Harbin Pharmaceutical Group Co.; Purelife bioscience Co., Ltd; Procera Health; Natural Factors; and LIQUID HEALTH, INC. are among the leading companies operating in the brain health supplements market.

The report segments the brain health supplements market as follows:

Based on product, the brain health supplements market is segmented into natural molecules, herbal extracts, and vitamins & minerals. In terms of application, the market is segmented into memory enhancement, attention & focus, depression & mood, sleep & recovery, antiaging & longevity, and others. The brain health supplements market, by dosage form, is segmented into tablets, capsules, and others. Based on distribution channel, the brain health supplements market is segmented into supermarket & hypermarket, drug store, online, and others. In terms of age category, the market is segmented into adults, children, and elderly. By geography, the brain health supplements market is segmented into North America (US, Canada, and Mexico), Europe (UK, Germany, France, Italy, Spain, and Rest of Europe), Asia Pacific (China, Japan, India, Australia, South Korea, and Rest of Asia Pacific), the Middle East & Africa (UAE, Saudi Arabia, South Africa, and Rest of Middle East & Africa), and South & Central America (Brazil, Argentina, and Rest of South & Central America).

 About US

The Insight Partners is a one stop industry research provider of actionable intelligence. We help our clients in getting solutions to their research requirements through our syndicated and consulting research services. We specialize in industries such as Semiconductor and Electronics, Aerospace and Defense, Automotive and Transportation, Biotechnology, Healthcare IT, Manufacturing and Construction, Medical Device, Technology, Media and Telecommunications, Food and Beverages, Consumers and Goods, Chemicals and Materials.

Contact US

Contact Person : Sameer Joshi .

Phone : [phone]

E-mail : [email protected]

[innovationtrends]

Pharmaceutical Fluid Handling Market Size, Growth, Industry Trends, Global Demand, and Forecast 2023-2028

The pharmaceutical fluid handling market is projected to reach US$ 14,209.40 million by 2028; registering at a CAGR of 4.7% from 2022 to 2028, according to a new research study conducted by The Insight Partners.

Equipment Segment Dominated Pharmaceutical Fluid Handling Market in 2021

Increasing drug production and growing adoption of single-use systems in the pharmaceutical industry are the factors that contribute to the pharmaceutical fluid handling market growth. However, high price of failed clinical trials restricts the market growth.

Grab PDF to Know More (Including Table, Full TOC and Figures) @ https://www.theinsightpartners.com/sample/TIPRE00029767/  

Increase in Vaccine Production Provides Opportunity to Pharmaceutical Fluid Handling Market

Vaccines strengthen the immune system of different age groups, providing protection against infectious diseases. In the past few decades, effective immunization has eliminated polio and smallpox, which registered high mortality rates. In recent years, there has been an increase in vaccination demand due to the rising incidences of viral and bacterial infectious diseases. Further, government foundations, hospitals, and pharmaceutical companies are focusing on regular vaccine administration by providing cost-effective immunization globally. This is boosting the demand for vaccine production, which is likely to promote the growth of the pharmaceutical fluid handling market. For instance, the Indian Universal Immunization Programme (UPI) rolled out its pneumococcal conjugate vaccine to 21 lakh children. Additionally, government funding and company investments are stimulating R&D to launch new products. According to World Health Organization, in November 2022, a total of 16 billion vaccine doses, valued at US$ 141 billion, were supplied in 2021, which is approximately three times more than the doses supplied in 2019, i.e., 5.8 billion. The Serum Institute of India (SII) postponed HPV vaccine production for two years due to the focus on the development of COVID-19 vaccines; however, it will begin supplying HPV vaccine to the Government of India by 2023 in small quantities. Thus, an increase in vaccine production is anticipated to create an opportunity for the pharmaceutical fluid handling market during the forecast period.

Based on offering, the global pharmaceutical fluid handling market is segmented into equipment and solutions and services. In 2021, the equipment segment held the largest share of the market, and it is expected to register the highest CAGR during 2022–2028. The equipment & solutions segment is further segmented into metering pumps and capsule equipment (filling/sorting), mixing equipment and valves, thermal processing equipment (coolers/chillers/dryers/heat-exchangers), x-ray inspection systems, tanks for holding liquids and flow control products, filters/filter sets (pre-filters/ sterilizing grade filters/ virus filters), powder handling bags, sterile connectors/disconnectors and membrane filter cartridges, and others. Based on tubing, the market is segmented into TPE, PVC, and silicone.

CIRCOR International Inc, Parker Hannifin Corp, Danaher Corp, Spirax Sarco Engineering plc, Merck KGaA, Rochling SE & Co KG, RAUMEDIC AG, Tef Cap Industries Inc, Fraser Ross Ltd, and Australian Fluid Handling Pty Ltd are the key companies operating in the pharmaceutical fluid handling market.

The report segments the pharmaceutical fluid handling market as follows:

The pharmaceutical fluid handling market is segmented on the basis of offering, tubing, application, usage, end user, and geography. Based on offering, the market is segmented into equipment & solutions and services. Based on tubing, the market is segmented into TPE, PVC, and silicone. Based on application, the market is segmented into fluid handling and management, fluid preparation, integration and automation, aseptic processing, buffer management, and others. Based on usage, the market is segmented into cough syrup, intravenous products, complex APIs, and others. Based on end user, the market is segmented into biotechnology companies, pharmaceutical and medical companies, and others.

In terms of geography, the pharmaceutical fluid handling market is segmented into North America (the US, Canada, and Mexico), Europe (the UK, Germany, France, Italy, Spain, and the Rest of Europe), Asia Pacific (China, Japan, India, Australia, South Korea, and the Rest of Asia Pacific), the Middle East & Africa (the UAE, Saudi Arabia, Africa, and the Rest of Middle East & Africa), and South & Central America (Brazil, Argentina, and the Rest of South & Central America).

About US

The Insight Partners is a one stop industry research provider of actionable intelligence. We help our clients in getting solutions to their research requirements through our syndicated and consulting research services. We specialize in industries such as Semiconductor and Electronics, Aerospace and Defense, Automotive and Transportation, Biotechnology, Healthcare IT, Manufacturing and Construction, Medical Device, Technology, Media and Telecommunications, Food and Beverages, Consumers and Goods, Chemicals and Materials.

Contact US

Contact Person : Sameer Joshi .

Phone : [phone]

E-mail : [email protected]

[innovationtrends]

Aquaculture Vaccines Market Report, Share, Trends, Business Growth and Major Driving Factors 2028

According to our new research study on “Aquaculture Vaccines Market Forecast to 2028 – COVID-19 Impact and Global Analysis – by Type of Vaccine, Species, and Route of Administration,” the market is expected to grow from US$ 245.13 million in 2021 to US$ 569.72 million by 2028; it is estimated to grow at a CAGR of 12.9% from 2022 to 2028.

Grab PDF to Know More (Including Table, Full TOC and Figures) @ https://www.theinsightpartners.com/sample/TIPRE00005403/  

The report highlights trends prevailing in the market and factors driving its growth. The market growth is mainly attributed to the growing aquaculture industry and surging demand for aquatic animal-derived food products. However, strict regulatory policies for the approval of vaccines and the high cost of vaccines hamper the market growth.

Based on type of vaccine, the aquaculture vaccines market is segmented into live vaccines, inactivated vaccines, and other vaccines. The inactivated vaccines segment held the largest share of the market in 2021. However, the live vaccines segment is anticipated to register the highest CAGR in the market during the forecast period. The inactivated vaccine is prepared by physical or chemical treatment of the pathogen so that the organisms become inactive (loses replication capability) but maintain their immunogenicity. The vaccine is usually prepared with a virulent strain and is immunogenic. A few examples of chemical inactivating agents are formaldehyde, glutaraldehyde, and beta propiolactone; they change the structural conformation or cross-link the structures and ultimately inactivate the organisms. Advantages of such vaccines are no possibility of reversion, no shedding and contamination of an environment, and stability, thus less need for a cold chain.

The COVID-19 pandemic hampered the manufacturing, healthcare, aerospace & defense, and construction industries in 2020. The pandemic has had adverse impacts on aquaculture value chains. The crisis has negatively affected the aquaculture input supply, thus affecting the aquaculture vaccine market. Inadequate and irregular input supply raised concerns about aquaculture practices, which may undermine future production. In North America, the aquaculture sector was jeopardized by the COVID-19 crisis due to disruptions in input supply and output distribution. The pandemic severely disrupted the marketing of aquaculture products. Globally, the crisis has also affected the livelihoods of millions of people working in the aquaculture sector. Moreover, reduced employment and lower incomes during the pandemic have affected seafood consumption across the world.

Impacts of COVID-19 on fisheries and aquaculture affected supply and demand. Transport and border restrictions reduced the supply. The pandemic and sluggish overseas markets impacted India’s seafood sector as well. The country exported 11,49,341 metric ton of marine products (worth US$ 5.96 billion) during FY 2020–2021, a decrease of 10.8% as compared to seafood export of 12,89,651 metric ton during 2019–2020.

Various measures were taken to mitigate the impact of the pandemic, which would also enable the post-pandemic recovery of the aquaculture sector and the aquaculture vaccine market.

AquaTactics Fish Health, HIPRA SA, Merck & Co Inc, Microsynbiotix Ltd, Indian Immunologicals Ltd, Nisseiken Co Ltd, Zoetis Inc, VETERQUIMICA SA, Phibro Animal Health Corp, Elanco Animal Health Inc., Tecnovax SA are among the leading companies operating in the aquaculture vaccines market.

The report segments the global aquaculture vaccines market as follows:

The aquaculture vaccines market is segmented on the basis of type of vaccine, species, route of administration, and geography. Based on type of vaccine, the market is segmented into live vaccines, inactivated vaccines, and other vaccines. Based on species, the market is segmented into tilapia, trout, salmon, shrimps, and others. By route of administration, the aquaculture vaccines market is segmented into injection vaccines, immersions vaccines, and oral vaccines. Based on geography, the market is segmented into North America (the US, Canada, and Mexico), Europe (France, Germany, the UK, Spain, Italy, Norway, Egypt, and the Rest of Europe), APAC (China, India, Japan, Australia, South Korea, Indonesia, New Zealand, and the Rest of APAC), the Middle East & Africa (Saudi Arabia, the UAE, South Africa, and the Rest of MEA), and South & Central America (Brazil, Argentina, Chile, and the Rest of SCAM).

About US

The Insight Partners is a one stop industry research provider of actionable intelligence. We help our clients in getting solutions to their research requirements through our syndicated and consulting research services. We specialize in industries such as Semiconductor and Electronics, Aerospace and Defense, Automotive and Transportation, Biotechnology, Healthcare IT, Manufacturing and Construction, Medical Device, Technology, Media and Telecommunications, Food and Beverages, Consumers and Goods, Chemicals and Materials.

Contact US

Contact Person : Sameer Joshi .

Phone : [phone]

E-mail : [email protected]

[innovationtrends]

Pulmonary Arterial Hypertension Market Share, Analysis Report Trends by Types, Applications and Forecast 2028

The pulmonary arterial hypertension market is expected to grow from US$ 7,369.89 million in 2021 to US$ 10,889.08 million by 2028; it is estimated to grow at a CAGR of 5.8% from 2022 to 2028.

The pulmonary arterial hypertension market is segmented on the basis of drug, type, route of administration, distribution channel, and geography. The report offers insights and in-depth analysis of the pulmonary arterial hypertension market, emphasizing various parameters such as dynamics, trends, and opportunities of the market and competitive landscape analysis of leading market players across various regions. It also includes the impact analysis of COVID–19 pandemic on pulmonary arterial hypertension market across the regions.

Grab PDF to Know More (Including Table, Full TOC and Figures) @ https://www.theinsightpartners.com/sample/TIPRE00005221/  

Rising Approvals of Pulmonary Arterial Hypertension Drugs Drives Market Growth

In September 2022, Toray Industries, Inc. received approval from China’s National Medical Products Administration (NMPA) for Careload tablets to treat pulmonary arterial hypertension (PAH). Careload is an orally administered sustained-release formulation of beraprost sodium, a prostacyclin derivative (PGI2).

In May 2022, United Therapeutic Corporation received US Food and Drug Administration (FDA) approval for Tyvaso DPI (treprostinil) inhalation powder to treat pulmonary hypertension associated with interstitial lung disease (PH-ILD; WHO Group 3) and pulmonary arterial hypertension (PAH; WHO Group 1) to enhance exercise ability.

In November 2021, the US FDA granted tentative approval for Yutrepia (treprostinil) inhalation powder. Yutrepia is indicated to treat PAH to improve exercise ability in adult patients with New York Heart Association (NYHA) Functional Class II-III symptoms.

In July 2021, The Janssen Pharmaceutical Companies of Johnson & Johnson received FDA approval for UPTRAVI (selexipag) injection for intravenous (IV) to treat PAH; WHO Group I in adult patients with WHO functional class (FC) II–III, who are temporarily unable to take oral therapy.

In August 2021, Aerami Therapeutics, Inc. announced that the FDA granted the company orphan drug designation for imatinib to treat PAH patients. AER– 901, a drug-device combination product candidate for inhaled imatinib for the treatment of PAH, is in a Phase 1 trial with completion targeted for the end of 2021.

Drug-Based Insights

Based on drug, the pulmonary arterial hypertension market is segmented into endothelin receptor antagonists (ERAs), prostacyclin and prostacyclin analogs, sGC stimulators, and pde-5 dipsticks. The prostacyclin and prostacyclin analogs segment held the largest market share in 2021 and is anticipated to register the highest CAGR during 2022–2028. Prostacyclin is a small lipid eicosanoid molecule, also known as prostaglandin, I-2 (PGI-2), produced by endothelial cells and acts locally, inhibiting platelet activation and causing vasodilation. Prostacyclin dilates blood vessels, improves blood flow by preventing the proliferation of vascular smooth muscle cells, and prevents blood clotting by inhibiting platelet aggregation. Prostacyclin analogs have been developed as therapies for PAH. PAH prostacyclin analogs are synthetic forms of prostacyclin, a natural substance produced in the body. Patients affected by PAH tend to have reduced prostacyclin levels, leading to blood vessel constriction and hypertension. PAH prostacyclin analogs supplement the requirement and mimic the action of natural prostacyclin to reduce pulmonary hypertension and reduce associated symptoms.

Route of Administration-Based Insights

Based on route of administration, the pulmonary arterial hypertension market is segmented into oral, intravenous/subcutaneous, and inhalational. The oral segment held the largest market share in 2021 and is anticipated to register the highest CAGR during the forecast period. Orally administered agents used for the treatment of symptomatic, moderate-to-severe PAH include sildenafil and the endothelin (ET) receptor antagonists (ERAs), bosentan and sitaxentan (sitaxsentan), and abrisentan oral ET(A) receptor-selective ERA, with higher ET receptor affinity than bosentan. Moreover, new oral drugs for treating PAH include macitentan, riociguat, and treprostinil. Ambrisentan is an endothelin receptor antagonist indicated for treating PAH; WHO Group 1 and delay clinical worsening. In combination with tadalafil, ambrisentan is indicated to reduce the risks of disease progression and hospitalization for worsening PAH, and to improve exercise ability.

Distribution Channel-Based Insights

Based on distribution channel, the pulmonary arterial hypertension market is segmented into hospital pharmacies and clinics, online pharmacies, and retail pharmacies. The hospital pharmacies and clinics segment held the largest market share in 2021 and is anticipated to register the highest CAGR during the forecast period. Hospital pharmacy strives to continuously maintain and improve patients' medication management and pharmaceutical care to the highest standards in a hospital setting. Pharmacists in this field are responsible for dispensing medications, quality testing, formulating and re-formulating dosage forms, monitoring, reporting drug safety, and preparing budgets for medications.

About US

The Insight Partners is a one stop industry research provider of actionable intelligence. We help our clients in getting solutions to their research requirements through our syndicated and consulting research services. We specialize in industries such as Semiconductor and Electronics, Aerospace and Defense, Automotive and Transportation, Biotechnology, Healthcare IT, Manufacturing and Construction, Medical Device, Technology, Media and Telecommunications, Food and Beverages, Consumers and Goods, Chemicals and Materials.

Contact US

Contact Person : Sameer Joshi .

Phone : [phone]

E-mail : [email protected]

[innovationtrends]

Sutherlandia Extract Market Share, Analysis Report Trends by Types, Applications and Forecast 2028

The Sutherlandia Extract Market is a specialized and in-depth study of the healthcare industry with a special focus on the global market trend analysis. The report aims to provide an overview of the Sutherlandia Extract Market with detailed market segmentation by type, applications, end-user, and geography. The report provides key statistics on the market status of the leading Sutherlandia Extract Market players and offers key trends and opportunities in the market.

The report also includes the profiles of key companies along with their SWOT analysis and market strategies in the Sutherlandia Extract Market. In addition, the report focuses on leading industry players with information such as company profiles, components, and services offered, financial information of the last 3 years, and the key development in the past five years.

Grab PDF to Know More (Including Table, Full TOC and Figures) @ https://www.theinsightpartners.com/sample/TIPRE00029343/  

Top Key Players:- Afriplex, Medico Herbs, Global Fusion Naturals, Afrinatural, Geva SA, The sutherlandia Company, Afrigetics CC, Body and Mind, TMG Health, Qualfon and Others

It is an African legume that has traditionally been used as a native medicine for a variety of ailments. It aids the body in rooting out or cleaning out viruses that may be present and can improve the functioning of lymph nodes, thymus glands, and other parts of the body. Sutherlandia extract has the ability to reverse the destructive process of viruses in the body, allowing the poisons to be unraveled and corrected. Sutherlandia extract also has anti-diabetic properties, because it normalizes insulin levels and glucose uptake in peripheral tissues while suppressing intestinal glucose uptake.

Drivers:

 The growing awareness about Sutherlandia extract in the pharmaceutical industry is anticipated to propel the growth of the market during the forecast period.

 The rising prevalence of chronic diseases such as cancer and diabetes across the globe is expected to spur market growth in the coming years.

 Increasing usage of Sutherlandia extracts in dietary supplements and other nutritional products

Restraints:

 Side effects of sutherlandia extract such as slight dizziness, diarrhea, and dry mouth, among others can impede the market growth.

The report analyzes factors affecting the market from both the demand and supply side and further evaluates market dynamics affecting the market during the forecast period i.e., drivers, restraints, opportunities, and future trends The report also provides exhaustive PEST analysis for all five regions namely; North America, Europe, APAC, MEA, and South And Central America after evaluating political, economic, social and technological factors affecting the Sutherlandia Extract Market in these regions.

Table of Contents                     

Report Overview: It includes the objectives and scope of the study and gives highlights of key market segments and players covered. It also includes years considered for the research study.

Executive Summary: It covers industry trends with high focus on market use cases and top market trends, market size by regions, and global market size. It also covers market share and growth rate by regions.

Key Players: Here, the report concentrates on mergers and acquisitions, expansions, analysis of key players, establishment date of companies, and areas served, manufacturing base, and revenue of key players.

Breakdown by Product and Application: This section provides details about market size by product and application.

Regional Analysis: All of the regions and countries analyzed in the report are studied on the basis of market size by product and application, key players, and market forecast.

Profiles of International Players: Here, players are evaluated on the basis of their gross margin, price, sales, revenue, business, products, and other company details.

Market Dynamics: It includes supply chain analysis, analysis of regional marketing, challenges,

Continued....

Thanks for reading this article; you can also get individual chapter wise section or region wise report version like North America, Europe or Asia.

About Us:

The Insight Partners is a one stop industry research provider of actionable intelligence. We help our clients in getting solutions to their research requirements through our syndicated and consulting research services.

Contact Us:

The Insight partners,

Phone: [phone]

Email: [email protected]

[innovationtrends]

Cancer Vaccines Market Size, Share, Analysis Report by Types, Applications and Forecast 2027

According to our new market research study on "Cancer Vaccines Market to 2027 – Global Analysis and Forecast by Technology, Type, Indication, and End User," the market is expected to reach US$ 15,845.59 million by 2027 from US$ 4,568.82 million in 2019; it is estimated to grow at a CAGR of 17.2% from 2020 to 2027. The report highlights trends prevailing in the global cancer vaccines market, and the drivers and restraints pertaining to the market growth.

Grab PDF to Know More (Including Table, Full TOC and Figures) @ https://bit.ly/40iZbpi

Based on technology, the cancer vaccines market is segmented into dendritic cells cancer vaccines, recombinant cancer vaccines, antigen cancer vaccines, whole cell cancer vaccines, and viral vector cancer vaccines. In 2019, the recombinant cancer vaccines segment accounted for the largest share of the market, and it is further estimated to register the highest CAGR during the forecast period. Growth of the market for this segment is attributed to the escalating demand for effective vaccines and rising prevalence of cancer. In addition, strategic activities by service providers such as collaborations, mergers, acquisitions, and expansions are further accelerating the growth of the market.

The global cancer vaccines market growth is mainly attributed to factors such as increasing incidence of cancer worldwide, and rising number of initiatives taken by healthcare research organizations and key cancer vaccines companies. However, a limited number of commercially available vaccines for treatment of cancer and higher cost of cancer vaccines hinder the market growth.

CSL Limited, ADURO BIOTECH INC., Astellas Pharma Inc., Merck & Co., Inc., Sanofi, Bristol-Myers Squibb Company, Glaxosmithkline Plc., Dendreon, ASTRAZENECA PLC., and OSE Immunotherapeutics are among the leading companies operating in the cancer vaccines market.

Cancer is among the leading cause of deaths across the globe and is profoundly affecting the quality of life. Thus, cancer would be a burden on society if not diagnosed and treated on time. According to the World Health Organization (WHO), in 2018, approximately 9.6 million deaths reported across the globe were due to cancer. Furthermore, the National Cancer Institute predicted that in 2018, approximately 1,735,350 new cancer cases would be diagnosed in the US. Approximately, 1.9 million new cancer cases and 693,000 cancer deaths were recorded in 2018, in North America. Prostate cancers are the most commonly diagnosed cancers among males in North America; however, breast cancer remains the leading cancer in females. As per the estimations by the American Cancer Society, breast cancer is the most common type of cancer in the US as it caused morbidity in ~234,087 people and lead to 41,904 deaths in 2018. Further, ~276,480 new cases are expected in the country in 2020. As per the Globocan 2019 report, in Germany, the total number of breast cancer cases in 2018 was 71,888, and the disease lead to ~19,376 deaths in that year. Additionally, lung cancer remains the most common cause of death in both sexes. It is estimated that the number of new cases of cancer incidence is 439.2 per 100,000 men and women per year. According to the National Health Profile, the cases of common cancers, including cervical, oral, and breast cancers have increased by 324% in India between 2017 and 2018.

Table of Contents                     

Report Overview: It includes the objectives and scope of the study and gives highlights of key market segments and players covered. It also includes years considered for the research study.

Executive Summary: It covers industry trends with high focus on market use cases and top market trends, market size by regions, and global market size. It also covers market share and growth rate by regions.

Key Players: Here, the report concentrates on mergers and acquisitions, expansions, analysis of key players, establishment date of companies, and areas served, manufacturing base, and revenue of key players.

Breakdown by Product and Application: This section provides details about market size by product and application.

Regional Analysis: All of the regions and countries analyzed in the report are studied on the basis of market size by product and application, key players, and market forecast.

Profiles of International Players: Here, players are evaluated on the basis of their gross margin, price, sales, revenue, business, products, and other company details.

Market Dynamics: It includes supply chain analysis, analysis of regional marketing, challenges,

Continued....

Thanks for reading this article; you can also get individual chapter wise section or region wise report version like North America, Europe or Asia.

About Us:

The Insight Partners is a one stop industry research provider of actionable intelligence. We help our clients in getting solutions to their research requirements through our syndicated and consulting research services.

Contact Us:

The Insight partners,

Phone: [phone]

Email: [email protected]

[innovationtrends]

Syringe Market Trends, Business Growth and Major Driving Factors 2027

According to our new market research study on “Syringe Market to 2027 – Global Analysis and Forecast – by Syringe Type, Application, Usability and End Use,” the market is expected to reach US$ 26,859.34 million by 2027 from US$ 12,649.46 million in 2019. The market is estimated to grow at a CAGR of 9.8% from 2020 to 2027. The report highlights trends prevailing in the market, and drivers and hindrances pertaining to the market growth.

Grab PDF to Know More (Including Table, Full TOC and Figures) @ https://www.theinsightpartners.com/sample/TIPRE00003521/  

Based on syringe type, the market is segmented into luer lock syringes, glass syringes, luer slip syringes, and others. In 2019, the glass syringes segment held the largest share of the market. The segment is expected to grow at the fastest CAGR during the forecast period. This segment is likely to witness a lucrative growth owing to low mechanical tolerance, and smooth movement of the plunger. Furthermore, properties of glass, such as nonreactive nature and heat and chemical resistance, are contributing to the growth of this segment. Moreover, glass syringes are highly compatible with various drug filing devices and are easy to manufacture, which makes them the most preferred syringes in market. In March 2019, Gerresheimer AG launched metal free 1 ml long Luer lock Gx RTF glass syringes to deliver highly complex, protein-based bioengineered molecules.

In the last few years, the health care sector has witnessed SARS, H1N1 and other outbreaks. However, the severity of the coronavirus makes the situation more complex. Additionally, with no vaccine in market and only preventive measure to self-isolation is hitting the various industries including Syringe manufacturing in the region. The US and Canada have witnessed spike in cases in just few days, which has compelled the governments to shut down all the business in order to prevent the spread of the virus.. As of July 2020, in the US, more than 5.0 million confirmed corona cases were recorded and more than 160 thousands deaths were reported due to COVID 19 Pandemic. The syringe market is expected to be hit by the pandemic the most due to increasing number of cases and lockdown in most of the cities.

Becton, Dickinson and Company ; Baxter International Inc.; Terumo Corporation; Vita Needle Company; Cardinal Health Inc.; NIPRO; RETRACTABLE TECHNOLOGIES, INC.; B. Braun Medical Inc.; AIR-TITE PRODUCTS CO., INC.; and HENKE-SASS, WOLF Ltd., are among the leading companies operating in the syringes market.

Chronic diseases, such as diabetes, cardiovascular disease, and cancer, are among the primary causes of death in adults. Infectious diseases are also the top causes of death in children and adults. Chronic and infectious diseases need continuous diagnosis using various medical tests,which requires the use of syringes.

According to the World Health Organization estimations, around 16 billion injections are administered every year globally. It has been estimated that chronic diseases would account for almost three-quarters of all deaths worldwide, and that 75% of deaths due to stroke, 71% of deaths due to ischemic heart disease (IHD), and 70% of deaths due to diabetes would occur in developing countries by 2020. Many of these patients are advised regular intravenous administration of insulin, which increases the demand for syringes.

Infectious diseases are the secondtop cause of deaths worldwide and are among the top causes of death in children under age 5. For instance, the Centers for Disease Control and Prevention (CDC) stated that 1.7 million hospital-acquired infections (HAIs) occurred in 2017, and 99,000 associated deaths occur annually in American hospitals. It is estimated that nearly 32.0% of HAIs are urinary tract infections (UTIs), 22.0% are surgical site infections (SSIs), 15.0% are pneumonia, and 14.0% are bloodstream infections (BSIs).

Table of Contents                     

Report Overview: It includes the objectives and scope of the study and gives highlights of key market segments and players covered. It also includes years considered for the research study.

Executive Summary: It covers industry trends with high focus on market use cases and top market trends, market size by regions, and global market size. It also covers market share and growth rate by regions.

Key Players: Here, the report concentrates on mergers and acquisitions, expansions, analysis of key players, establishment date of companies, and areas served, manufacturing base, and revenue of key players.

Breakdown by Product and Application: This section provides details about market size by product and application.

Regional Analysis: All of the regions and countries analyzed in the report are studied on the basis of market size by product and application, key players, and market forecast.

Profiles of International Players: Here, players are evaluated on the basis of their gross margin, price, sales, revenue, business, products, and other company details.

Market Dynamics: It includes supply chain analysis, analysis of regional marketing, challenges,

Continued....

Thanks for reading this article; you can also get individual chapter wise section or region wise report version like North America, Europe or Asia.

About Us:

The Insight Partners is a one stop industry research provider of actionable intelligence. We help our clients in getting solutions to their research requirements through our syndicated and consulting research services.

Contact Us:

The Insight partners,

Phone: [phone]

Email: [email protected]

[innovationtrends]

Homeopathy Market Share, Analysis Report Trends by Types, Applications and Forecast 2028

According to our latest study on “Homeopathy Market Forecast to 2028 – COVID-19 Impact and Global Analysis – by Source, Type, Application, Distribution Channel, and Geography,” the market is expected to reach US$ 13,518.62 million by 2028 from US$ 4,609.55 million in 2020; it is expected to grow at a CAGR of 14.4% from 2021 to 2028. The homeopathy market growth is attributed to the safety associated with homeopathic products and the rise in adoption of homeopathic medicine, which is expected to significantly increase the homeopathy market size. These drivers are expected to have significant impacts on the homeopathy market size. However, the stringent regulatory approval processes are expected to hamper the growth of the homeopathy market. The homeopathy market report also studies the ongoing opportunities and homeopathy market trends that can have a significant impact on the market growth potential.

Grab PDF to Know More (Including Table, Full TOC and Figures) @ https://www.theinsightpartners.com/sample/TIPRE00007419/  

Homeopathy is an alternative medical system that uses tiny amounts of natural substances from plants and minerals to stimulate the body’s healing process. Developed in the early 1700s in Germany, the system is popular in various regions, including Europe and Asia Pacific. It is widely used for allergies, migraines, depression, chronic fatigue syndrome, rheumatoid arthritis, irritable bowel syndrome, premenstrual syndrome, and other chronic diseases. The market report aims to develop an understanding of the homeopathy market scope and trends, which are expected to drive the market.

Based on source, the homeopathy market can be segmented into plants, animals, and minerals. The plant segment held the largest share of the homeopathy market in 2020 and is expected to continue its dominance during the forecast period. The plant segment is expected to witness the highest CAGR during the forecast period. A majority of homeopathic drugs are derived from plants or plant parts such as bark, flower, roots, leaves, and others. The segment is expected to hold almost two-thirds of the market during the forecast period.

There are growing customer concerns about the potential side effects of allopathic pharmaceutical drugs or regular medication. Hence, in Asian and European countries, consumers have been turning to alternative medicines, such as natural remedies, homeopathy, and other supplements. Some skilled homeopaths have also been promoting the benefits of alternative medicine, especially to patients suffering from chronic health conditions such as cardiovascular disease and cancer. Moreover, a study published in the Scandinavian Journal of Public Health, 2017 stated that alternative practices are primarily used in a complementary manner or in combination with traditional medicine. For instance, Curcuma longa (turmeric) is one of the natural ingredients that is steeped in homeopathic, a traditional form of medicine that originates from India. These conventional or alternative types of medicines are gaining popularity in Europe, and natural ingredient suppliers in developing countries are benefiting. As a result of the widespread use of homeopathic treatments, the industry is expected to expand.

In addition, for those who choose natural treatments such as naturopathy and homeopathy, invasive therapies to treat diseases and malignancies are used as a last resort. The market for orally administered medications and drugs without side effects is expected to grow in the coming years, which is likely to result in an increase in homeopathy product use. Allopathy contains strong medications; however, they are not appropriate for everyone. Furthermore, allopathic drugs are expensive and only have a transient effect on illnesses. Even after the prescribed drug's dose has been completed, the illness can return. Cases of drug abuse are another fact, owing to which people are shifting toward natural medications. Homeopathy remedies offer protective measures and boost immune system. Moreover, they are inexpensive, and they do not have side effects. This is expected to boost the sales of homeopathy products during the forecast period.

Homeopathy Market: Competition Landscape and Key Developments

Fourrts, Allen Healthcare Co. Ltd., Hahnemann Laboratories Inc, Boiron, Homeocan Inc, Hyland's Inc, Nelson Pharmacies Limited, Weleda UK, Biologische Heilmittel Heel GmbH, and Ainsworths (London) Limited are among the key companies operating in the homeopathy market. Product launches and expansion strategies are commonly adopted by these companies to expand their footprint worldwide. They also expand their respective product portfolios to meet the growing demand. The homeopathy market players offer innovative products to cater to constant and changing customer demands across the world, which also permits them to maintain their brand name globally.

Table of Contents                     

Report Overview: It includes the objectives and scope of the study and gives highlights of key market segments and players covered. It also includes years considered for the research study.

Executive Summary: It covers industry trends with high focus on market use cases and top market trends, market size by regions, and global market size. It also covers market share and growth rate by regions.

Key Players: Here, the report concentrates on mergers and acquisitions, expansions, analysis of key players, establishment date of companies, and areas served, manufacturing base, and revenue of key players.

Breakdown by Product and Application: This section provides details about market size by product and application.

Regional Analysis: All of the regions and countries analyzed in the report are studied on the basis of market size by product and application, key players, and market forecast.

Profiles of International Players: Here, players are evaluated on the basis of their gross margin, price, sales, revenue, business, products, and other company details.

Market Dynamics: It includes supply chain analysis, analysis of regional marketing, challenges,

Continued....

Thanks for reading this article; you can also get individual chapter wise section or region wise report version like North America, Europe or Asia.

About Us:

The Insight Partners is a one stop industry research provider of actionable intelligence. We help our clients in getting solutions to their research requirements through our syndicated and consulting research services.

Contact Us:

The Insight partners,

Phone: [phone]

Email: [email protected]

[innovationtrends]

Hospital Bed Market Report, Share, Trends, Business Growth and Major Driving Factors 2028

According to our latest study on "Hospital Bed Market Forecast to 2028 – COVID-19 Impact and Global Analysis – by Type, Usage, Application, and End User," the market is expected to grow from US$ 3,214.96 million in 2021 to US$ 4,688.96 million by 2028; it is expected to grow at a CAGR of 5.7% from 2022 to 2028. The report highlights the key factors driving the market growth and prominent players with their developments in the.

Top Key Players:- Hill-Rom Holdings, Inc. (Baxter), Stryker, Arjo, Invacare Corporation, PARAMOUNT BED CO., LTD., GF Health Products, Inc., Malvestio SpA, Span America (Savaria Corporation), Savion Industries, Stiegelmever GmbH & Co. KG. and Others

Get Sample PDF Brochure of Hospital Bed Market Size - COVID-19 Impact and Global Analysis with Strategic Developments at: https://www.theinsightpartners.com/sample/TIPRE00029326  

Based on type, the global hospital bed market is segmented into semi-electric, electric, and manual beds. In 2021, the semi-electric segment held the largest share of the market. The introduction of smart technologies in medical beds is anticipated to offer significant opportunities to the market in the projected period. Based on usage, the global hospital bed market is segmented into acute care beds, long-term care beds, psychiatric care beds, and others. The long-term care beds segment is expected to have high market share in the market. Based on end user, the global hospital bed market is segmented into hospitals & clinics, elderly care facilities, ambulatory surgical centers, and home care settings. The hospitals & clinics segment accounted for the largest share of the market in 2021. Based on application, the global hospital bed market is bifurcated into non-intensive and intensive. In 2021, the non-intensive segment held a larger share of the market, and it is further expected to register the fastest CAGR during the forecast period.

The global hospital bed market growth is mainly attributed to the increased prevalence of chronic diseases. According to the National Health Council report, ~40 million Americans face constraints in their routine activities as they suffer from one or more chronic health conditions. Incurable chronic diseases affect ~133 million Americans, representing more than 40% of the total population as per the published report in 2019. Many live with one or more chronic illnesses, such as diabetes, heart disease, or depression, but with two or more conditions. Such a high prevalence of chronic diseases may result in a more significant requirement for hospitalization, which drives the demand for hospital beds. According to the estimates presented in a Department of Health & Children report, ~80% of the general practitioners' (GP) consultations and 60% of hospital bed requirements are related to chronic disease cases with associated complications. As per a report by the Data and Digital Health Unit, acute care hospital beds are available for curative care, accounting for 100,000 beds per population in Europe.

The COVID-19 pandemic has boosted the global hospital bed market growth. A surge in the prevalence of COVID-19 patients across the world has led to the increased demand for advanced healthcare services and infrastructure to manage the health crisis. Further, healthcare companies have launched new products to cope with the high demand for hospital beds during the pandemic. For instance, in 2020, Stryker Corporation launched emergency relief beds to meet the need for beds in hospitals.

REPORT HIGHLIGHTS

Our report on Hospital Bed Market cover following key parameters:

Comprehensive market analysis at global, regional and country level

Detailed PEST (Political, Economic, Social and Technological) factors impacting the market across key geographic regions such as North America, Europe, Asia Pacific, Middle East & Africa, and South America

Market dynamics (drivers, restraints, opportunities, and future trends) and impact analysis of drivers and restraints at short-term, mid-term and long-term

Market size and forecasts in terms of revenue; 2020 (historic), 2021 (base year), 2022 – 28 (forecast period)

In-depth market segmentation and deep dive regional and country level analysis of 18+ countries across 5 key regions

Key company profiles and industry landscape to provide latest market initiatives and competitive landscape

Impact of COVID`19 pandemic on ecosystem and the market

About Us:

The Insight Partners is a one stop industry research provider of actionable intelligence. We help our clients in getting solutions to their research requirements through our syndicated and consulting research services.

Contact Us:

The Insight partners,

Phone: [phone]

Email: [email protected]

[innovationtrends]

Hair Transplant Market Share, Analysis Report Trends by Types, Applications and Forecast 2025

According to The Insight Partners market research study titled ‘Hair Transplant Market to 2025 – Global Analysis and Forecasts by Procedure, Site of Transplant and Therapy, the global hair transplant market was valued at US$ 5,272.1Mn in 2017 and is estimated to reach US$ 28,627.6 Mn by 2025. The report highlights the trends prevalent in the global hair transplant market and the factors driving the market along with those that act as deterrents to its growth.

Get Sample PDF Brochure of Hair Transplant Market Size - COVID-19 Impact and Global Analysis with Strategic Developments at: https://www.theinsightpartners.com/sample/TIPHE100001111/  

The global hair transplant market is a mature market in the developing countries as well as in developing economies worldwide. The advancements in hair transplant procedures such as follicular unit extraction (FUE) and follicular unit strip surgery (FUSS) in the recent years are expected to bolster the market growth. Among the type of procedures, the demand for the hair transplant is significantly high for FUE, followed by FUSS. In FUE technique each hair graft is removed one by one from the donor site using a punch tool. The procedure is performed to restore the smaller area (number of grafts) compared to the FUSS method. Furthermore, declining cost of procedures can be another factor which likely to drive the growth of the hair transplant market during the forecast period.

Hair transplants in men are associated with male-pattern hair loss. However, in the demand for hair transplant procedures in women has increased over the past few years. Hair loss in women expresses in different patterns, generally is more diffuse as compared to men hair loss pattern and it can occur at any age. The increasing number of women with diffuse hair loss and hair thinning also is expected to propel the growth of the global hair transplant market. According to the International Society of Hair Restoration Surgery, in the US nearly. 21 million women suffer from hair loss which is nearly 40% of all the hair transplant patients.

The market for hair transplant is well established in the region of North America, owing to the awareness regarding medical practices and technological developments in the hair transplant. Various market players have been focusing towards shifting their customer base in North America. However, in Middle East & Africa, Turkey is one of the most popular destinations with affordable price ranges and skillful doctors for hair transplantation. The hair restoration industry has grown at a higher pace in the past decade in the country. Cheap hair transplant surgery is one of the major factor that bring visitors to Turkey. The recent advancements in FUE techniques have improved the process and brought the costs down in the country. Besides the cost, the doctor decides on the patient’s condition to decide which method is the most effective. The FUE is recommended for patient who had a hair transplantation before or for those with tight scalp.

The key players operating in the field of hair transplant market worldwide include Cole Instruments Inc., CAPILLUS, LaserCap Company, Apira Science, Harris FUE Instruments, HairMax Inc., THERADOME, FueInstrument, Shaanxi Xingmao Industry Co., Ltd, and Restoration Robotics, Inc. among others.

REPORT HIGHLIGHTS

Our report on Hair Transplant Market cover following key parameters:

Comprehensive market analysis at global, regional and country level

Detailed PEST (Political, Economic, Social and Technological) factors impacting the market across key geographic regions such as North America, Europe, Asia Pacific, Middle East & Africa, and South America

Market dynamics (drivers, restraints, opportunities, and future trends) and impact analysis of drivers and restraints at short-term, mid-term and long-term

In-depth market segmentation and deep dive regional and country level analysis of 18+ countries across 5 key regions

Key company profiles and industry landscape to provide latest market initiatives and competitive landscape

Impact of COVID`19 pandemic on ecosystem and the market

About Us:

The Insight Partners is a one stop industry research provider of actionable intelligence. We help our clients in getting solutions to their research requirements through our syndicated and consulting research services.

Contact Us:

The Insight partners,

Phone: [phone]

Email: [email protected]

[innovationtrends]

Budesonide Sprays Market Size, Growth, Industry Trends, Global Demand, and Forecast 2022-2028

The "Budesonide Sprays Market Analysis to 2028" is a specialized and in-depth study of the healthcare industry with/ a special focus on the global market trend analysis. The report aims to provide an overview of Budesonide Sprays market with detailed market segmentation by product, end-user. The Budesonide Sprays market is expected to witness high growth during the forecast period. The report provides key statistics on the market status of the leading players in Budesonide Sprays market and offers key trends and opportunities in the market.

The report also includes the profiles of key players in Budesonide Sprays market along with their SWOT analysis and market strategies. In addition, the report focuses on leading industry players with information such as company profiles, components and services offered, financial information of last 3 years, key development in past five years.

Get Sample PDF Brochure of Budesonide Sprays Market Size - COVID-19 Impact and Global Analysis with Strategic Developments at: https://www.theinsightpartners.com/sample/TIPRE00021852/  

Top Key Players:- Lunan Better Pharmaceutical,  Pfizer,  Allgen Pharmaceuticals,  Boehringer Ingelheim,  Squibb,  Manus Aktteva Biopharma LLP,  AstraZeneca,  Sandoz,  Chiesi Farmaceutici S.p.A and Others

The Budesonide Sprays market is driving due to market is expected to grow in coming years owing to factors such as increase in air pollution which can leads to high prevalence of asthma and the development of new drugs by market players. However, the adverse effect shown by budesonide such as sneezing, coughing, sore throat, dry throat, nosebleed, stomach pain and others are expected to impede the growth of budesonide sprays market.

Budesonide is used to control and prevent symptoms caused due to asthma. The medication belongs to corticosteroids drug class, which prevents inflammation in lungs to decrease the severity of asthma attack. Budesonide is available in many forms such as powders, tablets, and suspension. The budesonide inhalers have adverse effect such as nosebleed, dry throat, runny nose, sore throat and others. Moreover, excess dose of medication can lead to osteoporosis and fractures.

The report provides a detailed overview of the industry including both qualitative and quantitative information. It provides overview and forecast of the Budesonide Sprays Market based on various segments. It also provides market size and forecast estimates from year 2020 to 2028 with respect to five major regions, namely, North America, Europe, Asia-Pacific (APAC), Middle East and Africa (MEA) and South & Central America. The Budesonide Sprays Market by each region is later sub-segmented by respective countries and segments. The report covers analysis and forecast of 18 countries globally along with current trend and opportunities prevailing in the region.

The report analyzes factors affecting Budesonide Sprays Market from both demand and supply side and further evaluates market dynamics affecting the market during forecast period i.e., drivers, restraints, opportunities, and future trend. The report also provides exhaustive PEST analysis for all five regions namely, North America, Europe, APAC, MEA and South & Central America after evaluating political, economic, social, and technological factors effecting the Budesonide Sprays Market in these regions.

REPORT HIGHLIGHTS

Our report on Budesonide Sprays Market cover following key parameters:

Comprehensive market analysis at global, regional and country level

Detailed PEST (Political, Economic, Social and Technological) factors impacting the market across key geographic regions such as North America, Europe, Asia Pacific, Middle East & Africa, and South America

Market dynamics (drivers, restraints, opportunities, and future trends) and impact analysis of drivers and restraints at short-term, mid-term and long-term

Market size and forecasts in terms of revenue; 2020 (historic), 2021 (base year), 2022 – 28 (forecast period)

In-depth market segmentation and deep dive regional and country level analysis of 18+ countries across 5 key regions

Key company profiles and industry landscape to provide latest market initiatives and competitive landscape

Impact of COVID`19 pandemic on ecosystem and the market

About Us:

The Insight Partners is a one stop industry research provider of actionable intelligence. We help our clients in getting solutions to their research requirements through our syndicated and consulting research services.

Contact Us:

The Insight partners,

Phone: [phone]

Email: [email protected]

[innovationtrends]

Laboratory Animal Diet Market Share, Analysis Report Trends by Types, Applications and Forecast 2028

The global laboratory animal diet market size is expected to reach US$ 5,469.24 million by 2028, registering a CAGR of 5.3% from 2022 to 2028, according to a new research study conducted by The Insight Partners.

Standard Diet Segment to Dominate Laboratory Animal Diet Market from 2022 to 2028

The market growth is primarily attributed to the growing consumption of personalized medicines and the rising usage of animal models in virology. However, the high cost of laboratory animal diet hinders the growth of the market.

Get Sample PDF Brochure of Laboratory Animal Diet Market Size - COVID-19 Impact and Global Analysis with Strategic Developments at: https://www.theinsightpartners.com/sample/TIPRE00029750/  

Based on diet type, the laboratory animal diet market is segmented into standard diet, irradiated diet, and autoclavable diet. The standard diet segment held the largest share of the market in 2021. The standard diet is formulated to meet broad objectives at all life stages involved in feeding laboratory animals i.e., the nutrients that are in general needed for lab animals are already present in the standard diet. For example, the LabDiet canine diet meets the nutritional requirements of all canine species utilized in a laboratory and supports all life stages, including growth, maintenance, gestation, and lactation.

The traditional use of animal models in drug discovery establishes and demonstrates nonclinical proof of concept for specific drug molecules' safety, efficacy, and target of interest. Animal models can facilitate the development of personalized medicine approaches. Personalized medicine approaches need to be developed and preclinically tested in relevant cell and mouse models that ideally contain the human target sequences. The animal models used for personalized medicine research and drug discovery & development are provided with specific diet so that the animal model will react according to the human environment. Therefore, with the rising demand for personalized medicines, the laboratory animal diet market is growing substantially.

Envigo; Altromin Spezialfutter GmbH & Co. KG; LabDiet; SAFE; Dyets, Inc.; Special Diet Services; Specialty Feeds; Research Diet Inc.; Bio-Serv; and Krishna Valley Agrotech LLP. are among the key companies operating in the laboratory animal diet market.

The report segments the laboratory animal diet market as follows:

The laboratory animal diet market is segmented on the basis of diet type, animal, application, end user, and geography. Based on diet type, the market is segmented into standard diet, irradiated diet, and autoclavable diet. Based on animal, the laboratory animal diet market is segmented into mouse, cat, dog, rabbit, chicken and others. Based on application, the market is segmented into drug discovery & personalized medicine, regenerative medicine, pathology of infectious diseases, drug toxicity & efficacy testing, and others. Based on end user, the laboratory animal diet market is segmented into pharmaceutical & biopharmaceutical companies, research & academic institutes, and others.

Based on geography, the laboratory animal diet market is segmented into North America (the US, Canada, and Mexico), Europe (the UK, Germany, France, Italy, Spain, and the Rest of Europe), Asia Pacific (China, Japan, India, Australia, South Korea, and the Rest of Asia Pacific), the Middle East & Africa (the UAE, Saudi Arabia, South Africa, and the Rest of the Middle East & Africa), and South & Central America (Brazil, Argentina, and the Rest of South & Central America).

REPORT HIGHLIGHTS

Our report on Laboratory Animal Diet Market cover following key parameters:

Comprehensive market analysis at global, regional and country level

Detailed PEST (Political, Economic, Social and Technological) factors impacting the market across key geographic regions such as North America, Europe, Asia Pacific, Middle East & Africa, and South America

Market dynamics (drivers, restraints, opportunities, and future trends) and impact analysis of drivers and restraints at short-term, mid-term and long-term

Market size and forecasts in terms of revenue; 2020 (historic), 2021 (base year), 2022 – 28 (forecast period)

In-depth market segmentation and deep dive regional and country level analysis of 18+ countries across 5 key regions

Key company profiles and industry landscape to provide latest market initiatives and competitive landscape

Impact of COVID`19 pandemic on ecosystem and the market

About Us:

The Insight Partners is a one stop industry research provider of actionable intelligence. We help our clients in getting solutions to their research requirements through our syndicated and consulting research services.

Contact Us:

The Insight partners,

Phone: [phone]

Email: [email protected]

[innovationtrends]

Irritable Bowel Syndrome (IBS) Treatment Market Size, Growth, Industry Trends, Global Demand, and Forecast 2028

According to our latest study on “Irritable Bowel Syndrome (IBS) Treatment Market Forecast to 2028 – COVID-19 Impact and Global Analysis – by Type, Product, and Distribution Channel,” the market was valued at US$ 2,153.89 million in 2020 and is projected to reach US$ 4,600.30 million by 2028; it is expected to grow at a CAGR of 10.1% from 2021 to 2028. The report highlights the key factors driving the market growth and prominent players with their developments in the market.

Get Sample PDF Brochure of Irritable Bowel Syndrome (IBS) Treatment Market Size - COVID-19 Impact and Global Analysis with Strategic Developments at:  https://www.theinsightpartners.com/sample/TIPRE00006814/  

Based on type, the irritable bowel syndrome (IBS) treatment market is segmented into mixed IBS (IBS-M), IBS with diarrhea (IBS-D), and IBS with constipation (IBS-C). The mixed IBS (IBS-M) segment held the largest share of the market in 2020. Also, the same segment is expected to register the highest CAGR during 2021–2028. In the coming years, the rising prevalence of IBS among women and men is anticipated to propel the demand for the medicines that can treat combined symptoms of constipation and diarrhea. According to updated Rome IV criteria, the reverse condition of IBS-M is described as a model of hard or irregular stools in more than 25% of bowel movements. The prevalence is higher in the geriatric population. Therefore, the demand for medicines to treat mixed IBS is likely to grow significantly during the forecast period,

The growth of the irritable bowel syndrome (IBS) treatment market is primarily attributed to the key driving factors such as increasing IBS diseases prevalence and rising research & development activities. However, the limited number of product availability and treatment inefficiency hinder the market growth. Ironwood Pharmaceuticals, Inc.; AbbVie.; Sebela Pharmaceuticals, Inc.; Takeda Pharmaceutical Company Limited; Alfasigma S.p.A.; Astellas Pharma Inc.; AstraZeneca; Synthetic Biologics, Inc.; Bausch + Lomb Incorporated; and Lannett Company Inc are among the leading companies operating in the market.

Our report on Irritable Bowel Syndrome (IBS) Treatment Market cover following key parameters:

Comprehensive market analysis at global, regional and country level

Detailed PEST (Political, Economic, Social and Technological) factors impacting the market across key geographic regions such as North America, Europe, Asia Pacific, Middle East & Africa, and South America

Market dynamics (drivers, restraints, opportunities, and future trends) and impact analysis of drivers and restraints at short-term, mid-term and long-term

In-depth market segmentation and deep dive regional and country level analysis of 18+ countries across 5 key regions

Key company profiles and industry landscape to provide latest market initiatives and competitive landscape

Impact of COVID`19 pandemic on ecosystem and the market

About Us:

The Insight Partners is a one stop industry research provider of actionable intelligence. We help our clients in getting solutions to their research requirements through our syndicated and consulting research services.

Contact Us:

The Insight partners,

Phone: [phone]

Email: [email protected]

[innovationtrends]

https://dailybusinesspost.com/smart-glass-market-to-reach-us-11-73-bn-by-2027-2/